AstraZeneca’s Dapagliflozin tablets get DCGI nod for chronic kidney disease
AstraZeneca Pharma India on Saturday mentioned it has received approval from the Medicines Controller Common of India (DCGI) for Dapagliflozin…
Change Your Business
AstraZeneca Pharma India on Saturday mentioned it has received approval from the Medicines Controller Common of India (DCGI) for Dapagliflozin…
Huge functions are cancelled, dining places and non-necessary enterprises are closed, and in many states, inhabitants have been asked to…
Significant commercial residence insurance provider FM International extra communicable ailment protection as a common ingredient of its main product back…
WhatsApp us